Breaking Immersive Art Exhibit Transforms Former St. Vincent Medical Center FIFA Sets September 19 Deadline for $20 Million Offer Amidst Federation Vote Austrian Bell Foundry Blends Centuries-Old Craftsmanship with 3D Printing Major Russian Oil Refinery Damaged in Overnight Strike, Six Injured Kurosawa Ventures into Samurai Genre with New Film ‘The Samurai and the Prisoner’

Wednesday July 29, 2026

Reporter

Cullinan Therapeutics, Inc.

1Articles Published

4Communities Covered

Published Articles

Press Release

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

Jul 28